mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.03 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.03 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |